Moderate-to-Severe Psoriasis
Informa Healthcare (Verlag)
978-1-4200-8867-0 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
New to the Third Edition:
the addition of chapters on the use of infliximab, efalizumab, and Humera, as well as the latest status of clinical trials
the most up-to-date phototherapy and laser treatment modalities
stronger coverage of psoriatic arthritis
1. An Overview of Psoriasis. 2. Evaluating Psoriasis in Patients. 3. Topical Agents in the Treatment of Moderate-to-Severe Psoriasis. 4. The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe Psoriasis. 5. Systemic and Topical PUVA Therapy. 6. Therapy of Moderate-to-Severe Psoriasis with Methotrexate. 7. Systemic Retinoids. 8. Cyclosporine in the Treatment of Severe Psoriasis. 9. Combination, Rotational, and Sequential Therapy. 10. Pediatric Psoriasis. 11. Psoriatic Arthritis. 12. Etanercept for Treatment of Psoriasis and Psoriatic Arthritis. 13. Adalimumab in the Treatment of Psoriasis. 14. Infliximab in the Treatment of Psoriasis. 15. Efalizumab in the Treatment of Psoriasis. 16. Alefacept for Treatment of Psoriasis. 17. Ustekinumab and ABT-874. 18. The Immunomodulatory/Immunosuppressive Classification System. 19. Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of Psoriasis.
| Zusatzinfo | 80 Illustrations, color |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 794 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| ISBN-10 | 1-4200-8867-X / 142008867X |
| ISBN-13 | 978-1-4200-8867-0 / 9781420088670 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
